Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in hepatitis C therapies.

Expert opinion on pharmacotherapy - 1 Jan 2015

Mariño Zoe, Lens Sabela, Gambato Martina, Forns Xavier

Abstract excerpt

INTRODUCTION: The recent development of new direct acting antivirals constitutes a clinical revolution in the field of hepatitis C therapy. Different drugs with direct antiviral effects and very high potency have been developed, changing the current scenario and prognosis of hepatitis C-related liver disease. This review aims to clarify the current stage of the different antiviral strategies in patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Coinfection
Share to Imidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Transplantation

Share to Pyrrolidines

Share to Simeprevir

Share to Sofosbuvir

Share to Valine

Source

Identifiers

PMID: 26219918
DOI: 10.1517/14656566.2015.1070828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in hepatitis C therapies.PMID 26219918Read ↗

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.Semantic proximity Read ↗

What does the pharmacological future of treating chronic hepatitis C look like?Semantic proximity Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

The new era of hepatitis C virus therapy.Semantic proximity Read ↗

The hepatitis C revolution part 1: antiviral treatment options.Semantic proximity Read ↗

Update on hepatitis C treatment: systematic review of clinical trials.Semantic proximity Read ↗

Hepatitis C-A clinical review.Semantic proximity Read ↗

Novel therapies for hepatitis C - one pill fits all?Semantic proximity Read ↗

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.Semantic proximity Read ↗

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.